Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Ramat HaSharon, Israel
Sector
Health Tech & Life Sciences
About
Immunocord has developed a solution for Graft Engineering of Cord Blood for Enhanced Adoptive Immunotherapy against Solid Tumors.
Q&A
- What is Immunocord's primary focus?
- Immunocord focuses on Graft Engineering of Cord Blood for Enhanced Adoptive Immunotherapy Against Solid Tumors.
- When was Immunocord founded?
- Immunocord was founded in February 2016.
- What is Immunocord's current operational status?
- Immunocord is currently inactive, as of May 2018.
- Where is Immunocord headquartered?
- Immunocord is headquartered in Ramat HaSharon, Center District, Israel.
- How many employees does Immunocord have?
- Immunocord has 1-10 employees.
- Who is the founder and CEO of Immunocord?
- Amnon Pelz is the Founder & CEO of Immunocord.
- What is Immunocord's primary sector classification?
- Immunocord's primary sector is Health Tech & Life Sciences.
- What is Immunocord's current funding stage?
- Immunocord is in the Pre-Funding stage.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical Devices
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
medical-technologiesimmunotherapyoncologycancerimmunologystealthmode
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/12953513 |
Identifiers & details
| Founded | 2016-2 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, May 2018 |